Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
POW
Powered Brands
$10.13
$10.09
$9.74
$10.13
$260.23MN/A21,543 shs667 shs
TNR Gold Corp. stock logo
TNR
TNR Gold
C$0.06
-7.7%
C$0.06
C$0.05
C$0.08
C$11.09M0.7170,520 shs9,000 shs
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$177.07
$177.00
$103.67
$177.38
$16.26B1.06746,779 shsN/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
POW
Powered Brands
0.00%0.00%0.00%0.00%-0.05%
TNR Gold Corp. stock logo
TNR
TNR Gold
0.00%-7.69%+20.00%+9.09%-7.69%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
POW
Powered Brands
N/AN/AN/AN/AN/AN/AN/AN/A
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
POW
Powered Brands
2.00
Hold$41.00304.94% Upside
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
POW
Powered Brands
N/AN/A$0.09 per share106.77($0.59) per shareN/A
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AC$0.00 per share50.00C$0.01 per shareN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$3.17B5.13$5.07 per share34.94$22.92 per share7.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
POW
Powered Brands
$2.85MN/A0.00N/AN/A-67.46%3.24%N/A
TNR Gold Corp. stock logo
TNR
TNR Gold
C$8.19MC$0.041.50N/AN/AN/A-130.55%N/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$269.20M$3.9160.4330.11N/A8.50%18.45%8.08%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
POW
Powered Brands
N/AN/AN/AN/AN/A
TNR Gold Corp. stock logo
TNR
TNR Gold
N/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
POW
Powered Brands
N/A
0.47
0.47
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A
29.89
0.18
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/A
1.40
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
POW
Powered Brands
98.49%
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
86.96%

Insider Ownership

CompanyInsider Ownership
POW
Powered Brands
19.77%
TNR Gold Corp. stock logo
TNR
TNR Gold
15.65%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
POW
Powered Brands
225.70 million20.62 millionNot Optionable
TNR Gold Corp. stock logo
TNR
TNR Gold
N/A184.87 millionN/ANot Optionable
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
10,00091.84 millionN/AOptionable

PFP, TNR, CUL, POW, and VAR Headlines

SourceHeadline
Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon TechnologyVarian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon Technology
prnewswire.co.uk - April 25 at 5:58 PM
The effect of using a large language model to respond to patient messagesThe effect of using a large language model to respond to patient messages
thelancet.com - April 24 at 10:26 PM
CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024
prnewswire.co.uk - April 24 at 12:26 PM
Healthway Cancer Care Hospital offers world-class cancer care at affordable pricesHealthway Cancer Care Hospital offers world-class cancer care at affordable prices
businessmirror.com.ph - April 24 at 12:26 PM
Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”
bizjournals.com - April 22 at 1:59 PM
DelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightDelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finanznachrichten.de - April 18 at 6:35 PM
This device treats overactive bladder without drugs or surgeryThis device treats overactive bladder without drugs or surgery
medicaldesignandoutsourcing.com - April 18 at 6:35 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightGlobal Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finance.yahoo.com - April 18 at 6:35 PM
Raigmore Hospital in Scotland selects RayCareRaigmore Hospital in Scotland selects RayCare
finance.yahoo.com - April 17 at 3:14 PM
PH’s 1st dedicated cancer hospital rises in Taguig CityPH’s 1st dedicated cancer hospital rises in Taguig City
msn.com - April 15 at 10:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™
finance.yahoo.com - April 15 at 5:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarketsRobotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets
finanznachrichten.de - April 15 at 12:34 PM
Ayala cancer hospital ready to serve 10,000 patients this yearAyala cancer hospital ready to serve 10,000 patients this year
msn.com - April 11 at 2:56 PM
Global Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMIGlobal Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMI
fmiblog.com - April 8 at 6:11 PM
Next-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancerNext-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancer
eurekalert.org - April 8 at 1:10 PM
The Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggestsThe Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests
eurekalert.org - April 5 at 1:10 AM
Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032
fmiblog.com - April 4 at 1:43 AM
New method allows miniature robots and surgical instruments to achieve precise localization inside the bodyNew method allows miniature robots and surgical instruments to achieve precise localization inside the body
msn.com - April 2 at 3:39 PM
Global Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI studyGlobal Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI study
fmiblog.com - April 2 at 3:39 PM
Baxter International lands key FDA clearance for infusion pumpBaxter International lands key FDA clearance for infusion pump
chicagobusiness.com - April 1 at 4:57 PM
Govt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention TipsGovt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention Tips
msn.com - March 28 at 8:17 PM
Robots in Healthcare Market Future Looks Bright for Market Size with Soaring ProjectionsRobots in Healthcare Market Future Looks Bright for Market Size with Soaring Projections
taiwannews.com.tw - March 28 at 8:44 AM
Radiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGRRadiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGR
pharmiweb.com - March 25 at 8:52 AM
Kahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technologyKahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technology
thedailyrecord.com - March 20 at 1:36 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Powered Brands

NASDAQ:POW
Powered Brands does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Powered Brands was incorporated in 2020 and is based in New York, New York.
TNR Gold logo

TNR Gold

CVE:TNR
TNR Gold Corp. engages in the acquisition, exploration, and evaluation of mineral properties. The company explores for gold, copper, silver, and lithium deposits. It holds a 90% interest in the Shotgun gold project located in the southwestern Alaska. The company also holds royalty interests in the Los Azules Copper and Mariana Lithium projects located in Argentina. TNR Gold Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
Varian Medical Systems logo

Varian Medical Systems

NYSE:VAR
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.